Radius Recycling Publishes Fiscal Year 2024 Sustainability Report
Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia
Radius Recycling, Inc. (NASDAQ: RDUS) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Radius Recycling, Inc. (NASDAQ: RDUS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $22.00 price target on the stock.
Radius Recycling, Inc. (NASDAQ: RDUS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.